{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:02:33Z","timestamp":1790668953350,"version":"4.1.0"},"reference-count":258,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Centre, Poland","award":["2017\/27\/B\/NZ3\/00582"],"award-info":[{"award-number":["2017\/27\/B\/NZ3\/00582"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The complement system is an assembly of proteins that collectively participate in the functions of the healthy and diseased brain. The complement system plays an important role in the maintenance of uninjured (healthy) brain homeostasis, contributing to the clearance of invading pathogens and apoptotic cells, and limiting the inflammatory immune response. However, overactivation or underregulation of the entire complement cascade within the brain may lead to neuronal damage and disturbances in brain function. During the last decade, there has been a growing interest in the role that this cascading pathway plays in the neuropathology of a diverse array of brain disorders (e.g., acute neurotraumatic insult, chronic neurodegenerative diseases, and psychiatric disturbances) in which interruption of neuronal homeostasis triggers complement activation. Dysfunction of the complement promotes a disease-specific response that may have either beneficial or detrimental effects. Despite recent advances, the explicit link between complement component regulation and brain disorders remains unclear. Therefore, a comprehensible understanding of such relationships at different stages of diseases could provide new insight into potential therapeutic targets to ameliorate or slow progression of currently intractable disorders in the nervous system. Hence, the aim of this review is to provide a summary of the literature on the emerging role of the complement system in certain brain disorders.<\/jats:p>","DOI":"10.3390\/ijms22094675","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T10:41:58Z","timestamp":1619606518000},"page":"4675","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Aberrant Complement System Activation in Neurological Disorders"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-4497","authenticated-orcid":false,"given":"Karolina","family":"Ziabska","sequence":"first","affiliation":[{"name":"Mossakowski Medical Research Centre, NeuroRepair Department, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Ziemka-Nalecz","sequence":"additional","affiliation":[{"name":"Mossakowski Medical Research Centre, NeuroRepair Department, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pawelec","sequence":"additional","affiliation":[{"name":"Mossakowski Medical Research Centre, NeuroRepair Department, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sypecka","sequence":"additional","affiliation":[{"name":"Mossakowski Medical Research Centre, NeuroRepair Department, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-9495","authenticated-orcid":false,"given":"Teresa","family":"Zalewska","sequence":"additional","affiliation":[{"name":"Mossakowski Medical Research Centre, NeuroRepair Department, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-018-1066-z","article-title":"The role of the complement system in traumatic brain injury: A review","volume":"15","author":"Hammad","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","article-title":"Developments in anti-complement therapy; from disease to clinical trial","volume":"102","author":"Harris","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2016.12.017","article-title":"A review of human diseases caused or exacerbated by aberrant complement activation","volume":"52","author":"McGeer","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fncel.2014.00380","article-title":"Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis","volume":"8","author":"Orsini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement Biosynthesis in the Central Nervous System","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System","volume":"12","author":"Woodruff","year":"2009","journal-title":"NeuroMolecular Med."},{"key":"ref_8","first-page":"794","article-title":"Human brain trauma severity is associated with lectin complement pathway activation","volume":"39","author":"Fumagalli","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","article-title":"Complement: The Emerging Architect of the Developing Brain","volume":"41","author":"Coulthard","year":"2018","journal-title":"Trends Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101340","DOI":"10.1016\/j.smim.2019.101340","article-title":"Complement dysregulation in the central nervous system during development and disease","volume":"45","author":"Lee","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0464-8","article-title":"Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement","volume":"12","author":"Alawieh","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ricklin, D., Mastellos, D.C., and Lambris, J.D. (2019). Therapeutic targeting of the complement system. Nat. Rev. Drug Discov., 1.","DOI":"10.1038\/s41573-019-0055-y"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410400408","article-title":"Complement activation in the central nervous system following blood-brain barrier damage in man","volume":"40","author":"Lindsberg","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.4049\/jimmunol.0902214","article-title":"Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation","volume":"184","author":"Pedersen","year":"2010","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2013.12.013","article-title":"Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3","volume":"253","author":"Daborg","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000328238","article-title":"Plasma C3 and C3a Levels in Cryptogenic and Large-Vessel Disease Stroke: Associations with Outcome","volume":"32","author":"Stokowska","year":"2011","journal-title":"Cerebrovasc. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.imbio.2015.04.001","article-title":"Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy","volume":"220","author":"Zhang","year":"2015","journal-title":"Immunobiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14336\/AD.2019.0119","article-title":"Significance of Complement System in Ischemic Stroke: A Comprehensive Review","volume":"10","author":"Ma","year":"2019","journal-title":"Aging Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000232544.90675.42","article-title":"Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia","volume":"99","author":"Mocco","year":"2006","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2008.07.044","article-title":"Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes","volume":"204","author":"Szegedi","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/exnr.1999.7273","article-title":"Expression of Receptors for Complement Anaphylatoxins C3a and C5a Following Permanent Focal Cerebral Ischemia in the Mouse","volume":"161","author":"Bernaudin","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.285.5427.595","article-title":"Neuronal Protection in Stroke by an sLex-Glycosylated Complement Inhibitory Protein","volume":"285","author":"Huang","year":"1999","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0361-9230(97)00408-5","article-title":"Complement Depletion Improves Neurological Function in Cerebral Ischemia","volume":"45","author":"Vasthare","year":"1998","journal-title":"Brain Res. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1523\/JNEUROSCI.23-28-09459.2003","article-title":"Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats","volume":"23","author":"Cowell","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2005.01.027","article-title":"The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats","volume":"380","author":"Figueroa","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12265-013-9508-6","article-title":"Role of Inflammation and Its Mediators in Acute Ischemic Stroke","volume":"6","author":"Jin","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0361-9230(99)00004-0","article-title":"Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke","volume":"48","author":"Lew","year":"1999","journal-title":"Brain Res. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)63744-3","article-title":"The Powerful Neuroprotective Action of C1-Inhibitor on Brain Ischemia-Reperfusion Injury Does Not Require C1q","volume":"164","author":"Rossi","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.164.10.5446","article-title":"Complement C1q Is Dramatically Up-Regulated in Brain Microglia in Response to Transient Global Cerebral Ischemia","volume":"164","author":"Schwaeble","year":"2000","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0140-6736(03)14412-1","article-title":"Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: Similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states","volume":"362","author":"Stevens","year":"2003","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.2009.06494.x","article-title":"C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production","volume":"112","author":"Fraser","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jnr.20775","article-title":"Temporal pattern of C1q deposition after transient focal cerebral ischemia","volume":"83","author":"Mack","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.1502287","article-title":"Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia","volume":"198","author":"Satyam","year":"2016","journal-title":"J. Immunol."},{"key":"ref_35","first-page":"425","article-title":"Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jnc.12111","article-title":"Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice","volume":"124","author":"Yang","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.4049\/jimmunol.165.10.5406","article-title":"Cutting edge: Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock","volume":"165","author":"Kildsgaard","year":"2000","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/glia.10069","article-title":"Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation","volume":"38","author":"Barnum","year":"2002","journal-title":"Glia"},{"key":"ref_39","first-page":"1048","article-title":"C3a Receptor Modulation of Granulocyte Infiltration after Murine Focal Cerebral Ischemia is Reperfusion Dependent","volume":"28","author":"Ducruet","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.30.1.134","article-title":"Mice Deficient in Mac-1 (CD11b\/CD18) Are Less Susceptible to Cerebral Ischemia\/Reperfusion Injury","volume":"30","author":"Soriano","year":"1999","journal-title":"Stroke"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-017-1749-z","article-title":"Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke","volume":"134","author":"Su","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ducruet, A.F., Zacharia, B.E., Sosunov, S.A., Gigante, P.R., Yeh, M.L., Gorski, J.W., Otten, M.L., Hwang, R.Y., DeRosa, P.A., and Hickman, Z.L. (2012). Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038664"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: A novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/brain\/aww314","article-title":"Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia","volume":"140","author":"Stokowska","year":"2016","journal-title":"Brain"},{"key":"ref_46","first-page":"620","article-title":"Interleukin-22 Regulates the Complement System to Promote Resistance against Pathobionts after Pathogen-Induced Intestinal Damage","volume":"41","author":"Hasegawa","year":"2014","journal-title":"Immunology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.156.6.2247","article-title":"Identification and characterization of complement C3 receptors on human astrocytes","volume":"156","author":"Gasque","year":"1996","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.145.9.2974","article-title":"A molecular and immunochemical characterization of mouse CREvidence for a single gene model of mouse complement receptors 1 and 2","volume":"145","author":"Molina","year":"1990","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1073\/pnas.93.8.3357","article-title":"Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2","volume":"93","author":"Molina","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased Complement Biosynthesis by Microglia and Complement Activation on Neurons in Huntington\u2019s Disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn3733","article-title":"Microglial cell-mediated depression","volume":"15","author":"Yates","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.neuroscience.2008.07.015","article-title":"Neuroprotection in stroke by complement inhibition and immunoglobulin therapy","volume":"158","author":"Arumugam","year":"2009","journal-title":"Neuroscience"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrd3011","article-title":"Therapeutic potential of complement modulation","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0700506104","article-title":"Intravenous Immunoglobulin (IVIG) Protects the Brain against Experimental Stroke by Preventing Com-plement-Mediated Neuronal Cell Death","volume":"104","author":"Arumugam","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-5-5","article-title":"Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 In Vitro and In Vivo","volume":"5","author":"Mukherjee","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1460-9568.2008.06575.x","article-title":"The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-\u03b1-independent manner","volume":"29","author":"Persson","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Cervera, A., Planas, A.M., Justicia, C., Urra, X., Jensenius, J.C., Torres, F., Lozano, F., and Chamorro, A. (2010). Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008433"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/STROKEAHA.113.004111","article-title":"Mannose-Binding Lectin Promotes Local Microvascular Thrombosis After Transient Brain Ischemia in Mice","volume":"45","author":"Cervera","year":"2014","journal-title":"Stroke"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/ATVBAHA.118.311058","article-title":"Mannose-Binding Lectin Drives Platelet Inflammatory Phenotype and Vascular Damage After Cerebral Ischemia in Mice via IL (Interleukin)-1\u03b1","volume":"38","author":"Orsini","year":"2018","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/156720211794520260","article-title":"The Contribution of Mannose Binding Lectin to Reperfusion Injury after Ischemic Stroke","volume":"8","author":"Morrison","year":"2011","journal-title":"Curr. Neurovascular Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12975-011-0104-2","article-title":"The Neuroprotective Effect of Genetic Mannose-Binding Lectin Deficiency Is Not Sustained in the Subacute Phase of Stroke","volume":"2","author":"Ducruet","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The Alternative Complement Pathway Propagates Inflammation and Injury in Murine Ischemic Stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The Classical Complement Cascade Mediates CNS Synapse Elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1523\/JNEUROSCI.3240-08.2008","article-title":"Inflammation Regulates Functional Integration of Neurons Born in Adult Brain","volume":"28","author":"Jakubs","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-3476(99)70458-0","article-title":"Interferons and cerebral palsy","volume":"134","author":"Grether","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0003-4975(97)01340-4","article-title":"Complement and Contact Activation during Cardiovascular Operations in Infants","volume":"65","author":"Sonntag","year":"1998","journal-title":"Ann. Thorac. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-0029-1220793","article-title":"The Role of Complement in Neurodevelopmental Impairment following Neonatal Hypoxic-Ischemic Encephalopathy","volume":"26","author":"Aly","year":"2009","journal-title":"Am. J. Perinatol."},{"key":"ref_69","first-page":"1333","article-title":"Inflammatory Gene Profiling in the Developing Mouse Brain after Hypoxia-Ischemia","volume":"24","author":"Maj","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.siny.2007.01.014","article-title":"Inflammation-induced preconditioning in the immature brain","volume":"12","author":"Mallard","year":"2007","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1479-5876-12-181","article-title":"Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway","volume":"12","author":"Shah","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/pr.2016.271","article-title":"Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy","volume":"81","author":"Shah","year":"2016","journal-title":"Pediatr. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/01.STR.0000182237.20807.d0","article-title":"C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice","volume":"36","author":"Ten","year":"2005","journal-title":"Stroke"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1096\/fj.13-230011","article-title":"Receptor for complement peptide C3a: A therapeutic target for neonatal hypoxic-ischemic brain injury","volume":"27","author":"Rousset","year":"2013","journal-title":"FASEB J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2017.01.001","article-title":"Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic\u2013ischemic brain injury","volume":"290","author":"Stokowska","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.12.008","article-title":"Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic\u2013ischemic central nervous system of human newborn infants","volume":"378","author":"Schultz","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3940(02)00271-9","article-title":"The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats","volume":"325","author":"Imm","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","article-title":"Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System","volume":"10","author":"Carpanini","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fnins.2019.01178","article-title":"Brain-Immune Interactions and Neuroinflammation After Traumatic Brain Injury","volume":"13","author":"Dinet","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2018.1471985","article-title":"Complement cascade on severe traumatic brain injury patients at the chronic unconscious stage: Implication for pathogenesis","volume":"18","author":"Bao","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00701-010-0737-z","article-title":"Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B","volume":"153","author":"Bellander","year":"2011","journal-title":"Acta Neurochir."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(96)00164-6","article-title":"Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury","volume":"73","author":"Kossmann","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1007\/s12035-017-0821-y","article-title":"Protein Biomarkers and Neuroproteomics Characterization of Microvesicles\/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury","volume":"55","author":"Manek","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal Levels of Complement-Derived Soluble Membrane Attack Complex (sC5b-9) Correlate with Blood-Brain Barrier Dysfunction in Patients with Traumatic Brain Injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J. Neurotrauma"},{"key":"ref_85","first-page":"860","article-title":"Effect of Soluble Complement Receptor-1 on Neutrophil Accumulation after Traumatic Brain Injury in Rats","volume":"15","author":"Kaczorowski","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Leinhase, I., Holers, V.M., Thurman, J.M., Harhausen, D., I Schmidt, O., Pietzcker, M., E Taha, M., Rittirsch, D., Huber-Lang, M., and Smith, W.R. (2006). Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci., 7.","DOI":"10.1186\/1471-2202-7-55"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-4-13","article-title":"Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: A randomized placebo-controlled study in mice","volume":"4","author":"Leinhase","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1523\/JNEUROSCI.2197-17.2018","article-title":"Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury","volume":"14","author":"Alawieh","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/CCM.0b013e318195998a","article-title":"C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice","volume":"37","author":"Longhi","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_90","first-page":"1070","article-title":"Central Nervous System-Targeted Complement Inhibition Mediates Neuroprotection after Closed Head Injury in Transgenic Mice","volume":"23","author":"Rancan","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2016.02.025","article-title":"Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains","volume":"617","author":"Rich","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2004.06.003","article-title":"Complement C3 and C5 play critical roles in traumatic brain cryoinjury: Blocking effects on neutrophil extravasation by C5a receptor antagonist","volume":"155","author":"Sewell","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_93","first-page":"1490","article-title":"The Role of Complement C3 in Intracerebral Hemorrhage-Induced Brain Injury","volume":"26","author":"Yang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-6-2","article-title":"Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice","volume":"6","author":"Stahel","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","article-title":"Inhibition of the Membrane Attack Complex of the Complement System Reduces Secondary Neuroaxonal Loss and Promotes Neurologic Recovery after Traumatic Brain Injury in Mice","volume":"192","author":"Fluiter","year":"2014","journal-title":"J. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1073\/pnas.1513698112","article-title":"An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice","volume":"112","author":"Ruseva","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","first-page":"938","article-title":"Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury","volume":"37","author":"Fumagalli","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000000399","article-title":"Mannose-Binding Lectin Is Expressed after Clinical and Experimental Traumatic Brain Injury and Its Deletion Is Protective","volume":"42","author":"Longhi","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_99","first-page":"1030","article-title":"Mannose Binding Lectin Gene Deficiency Increases Susceptibility to Traumatic Brain Injury in Mice","volume":"28","author":"Yager","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1089\/neu.2016.4941","article-title":"Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study","volume":"34","author":"Osthoff","year":"2017","journal-title":"J. Neurotrauma"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.spinee.2003.07.007","article-title":"Pathophysiology and pharmacologic treatment of acute spinal cord injury","volume":"4","author":"Kwon","year":"2004","journal-title":"Spine J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.smim.2016.03.015","article-title":"Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions","volume":"28","author":"Brennan","year":"2016","journal-title":"Semin. Immunol."},{"key":"ref_103","first-page":"287","article-title":"Complement elevation in spinal cord injury","volume":"44","author":"Rebhun","year":"1980","journal-title":"Ann. Allergy"},{"key":"ref_104","first-page":"335","article-title":"Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury","volume":"66","author":"Rebhun","year":"1991","journal-title":"Ann. Allergy"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1089\/neu.2004.21.1831","article-title":"Activation of Complement Pathways after Contusion-Induced Spinal Cord Injury","volume":"21","author":"Anderson","year":"2004","journal-title":"J. Neurotrauma"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"From the Cover: A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-5-26","article-title":"Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes In Vitro and In Vivo after spinal cord injury","volume":"5","author":"Nguyen","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0197-4580(96)00120-0","article-title":"Complement and clusterin in the injured nervous system","volume":"17","author":"Liu","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.1523\/JNEUROSCI.2823-08.2008","article-title":"Deficiency in Complement C1q Improves Histological and Functional Locomotor Outcome after Spinal Cord Injury","volume":"28","author":"Galvan","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neulet.2010.08.056","article-title":"Effects of C3 deficiency on inflammation and regeneration following spinal cord injury in mice","volume":"485","author":"Guo","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement Plays an Important Role in Spinal Cord Injury and Represents a Therapeutic Target for Improving Recovery following Trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: Evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02024-8","article-title":"The good, the bad, and the opportunities of the complement system in neurodegenerative disease","volume":"17","author":"Schartz","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","article-title":"New tricks for an ancient system: Physiological and pathological roles of complement in the CNS","volume":"102","author":"Tenner","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-016-0066-0","article-title":"The study of brain functional connectivity in Parkinson\u2019s disease","volume":"5","author":"Gao","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroscience.2014.12.008","article-title":"Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats","volume":"286","author":"Sharma","year":"2015","journal-title":"Neuroscience"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ageing\/afx196","article-title":"200 Years of Parkinson\u2019s disease: What have we learnt from James Parkinson?","volume":"47","author":"McDonald","year":"2018","journal-title":"Age Ageing"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.neuropsychologia.2009.12.014","article-title":"Dopaminergic medication boosts action-effect binding in Parkinson\u2019s disease","volume":"48","author":"Moore","year":"2010","journal-title":"Neuropsychologia"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.ps.31.020180.001421","article-title":"Chemistry of Mood and Emotion","volume":"31","author":"McGeer","year":"1980","journal-title":"Annu. Rev. Psychol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson\u2019s disease substantia nigra: An immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson\u2019s disease","volume":"342","author":"Goldknopf","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WCO.0b013e3280adc943","article-title":"Therapeutic approaches to inflammation in neurodegenerative disease","volume":"20","author":"Klegeris","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2006.07.014","article-title":"Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: Role of microglia","volume":"50","author":"Wang","year":"2007","journal-title":"Neurochem. Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2007.08.033","article-title":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","volume":"1178","author":"Liang","year":"2007","journal-title":"Brain Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic Lateral Sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1073\/pnas.1006869107","article-title":"Deficits in axonal transport precede ALS symptoms In Vivo","volume":"107","author":"Bilsland","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1517\/14728222.11.11.1415","article-title":"Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis","volume":"11","author":"Corona","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2018.06.007","article-title":"\u00d8berg; M\u00f8ller, K.; Garred, P. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis","volume":"102","author":"Pilely","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1085\/jgp.201611581","article-title":"The exceptionally high reactivity of Cys 621 is critical for electrophilic activation of the sensory nerve ion channel TRPA1","volume":"147","author":"Bahia","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-5728(84)90042-0","article-title":"Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients","volume":"6","author":"Donnenfeld","year":"1984","journal-title":"J. Neuroimmunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","article-title":"Relative sparing in Parkinson\u2019s disease of substantia nigra dopamine neurons containing calbindin-D28K","volume":"526","author":"Yamada","year":"1990","journal-title":"Brain Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0404.1985.tb01548.x","article-title":"High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"72","author":"Annunziata","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_140","first-page":"333","article-title":"Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis","volume":"9","author":"Yu","year":"2018","journal-title":"Biomed. Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1523\/JNEUROSCI.1470-07.2007","article-title":"Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS","volume":"27","author":"Ferraiuolo","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.05.044","article-title":"Gene expression analysis of the murine model of amyotrophic lateral sclerosis: Studies of the Leu126delTT mutation in SOD1","volume":"1160","author":"Fukada","year":"2007","journal-title":"Brain Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","article-title":"Complement components are upregulated and correlate with disease progression in the TDP-43Q331K mouse model of amyotrophic lateral sclerosis","volume":"15","author":"Lee","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"12066","DOI":"10.1073\/pnas.1300894110","article-title":"MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.0702230104","article-title":"Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons","volume":"104","author":"Lobsiger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skelet. Muscle"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"Chiu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1523\/JNEUROSCI.0525-17.2017","article-title":"Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKC\u03b6","volume":"37","author":"Coulthard","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","first-page":"E3","article-title":"Role for terminal complement activation in amyotrophic lateral sclerosis disease progression","volume":"111","author":"Woodruff","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2009.01.028","article-title":"The complement factor C5a receptor is upregulated in NFL\u2212\/\u2212 mouse motor neurons","volume":"210","author":"Humayun","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Wild","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic Profiling of Plasma in Huntington\u2019s Disease Reveals Neuroinflammatory Activation and Biomarker Candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Nayak, A., Ansar, R., Verma, S.K., Bonifati, D.M., and Kishore, U. (2021, February 08). Huntington\u2019s Disease: An Immune Perspective. Available online: https:\/\/www.hindawi.com\/journals\/nri\/2011\/563784\/.","DOI":"10.1155\/2011\/563784"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated Immune System in Patients with Huntington\u2019s Disease","volume":"36","author":"Leblhuber","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JHD-2012-120021","article-title":"Genetic Deficiency of Complement Component 3 does not Alter Disease Progression in a Mouse Model of Huntington\u2019s Disease","volume":"1","author":"Larkin","year":"2012","journal-title":"J. Huntington\u2019s Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10072-010-0376-4","article-title":"Cognitive impairment in early stages of multiple sclerosis","volume":"31","author":"Amato","year":"2010","journal-title":"Neurol. Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3174\/ajnr.A0788","article-title":"Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis","volume":"29","author":"Reich","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Aeinehband, S., Lindblom, R.P.F., Al Nimer, F., Vijayaraghavan, S., Sandholm, K., Khademi, M., Olsson, T., Nilsson, B., Ekdahl, K.N., and Darreh-Shori, T. (2015). Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122048"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/1352458512438238","article-title":"Systemic complement profiling in multiple sclerosis as a biomarker of disease state","volume":"18","author":"Ingram","year":"2012","journal-title":"Mult. Scler. J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0611-x","article-title":"Complement is activated in progressive multiple sclerosis cortical grey matter lesions","volume":"13","author":"Watkins","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2011.03.009","article-title":"Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis","volume":"234","author":"Li","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13550289609146888","article-title":"Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction","volume":"2","author":"Sanders","year":"1996","journal-title":"J. Neurovirology"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2016.04.003","article-title":"Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function","volume":"166\u2013167","author":"Lindblom","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_172","first-page":"251","article-title":"Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders","volume":"15","author":"Farrokhi","year":"2016","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2011.08.018","article-title":"Mannose binding lectin mediated complement pathway in multiple sclerosis","volume":"239","author":"Kwok","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12026-017-8961-8","article-title":"The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis","volume":"65","author":"Tatomir","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2990.1989.tb01231.x","article-title":"Immunocytochemical localization of the terminal complement complex in multiple sclerosis","volume":"15","author":"Compston","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-53","article-title":"Complement activation in multiple sclerosis plaques: An immunohistochemical analysis","volume":"2","author":"Ingram","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","article-title":"Multiple sclerosis: In Situ evidence for antibody and complement-mediated demyelination","volume":"43","author":"Storch","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/exnr.2001.7851","article-title":"Complement Activated C4d Immunoreactive Oligodendrocytes Delineate Small Cortical Plaques in Multiple Sclerosis","volume":"174","author":"Schwab","year":"2002","journal-title":"Exp. Neurol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0536-y","article-title":"Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis","volume":"6","author":"Michailidou","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/08916930600739605","article-title":"The complement system in central nervous system diseases","volume":"39","author":"Rus","year":"2006","journal-title":"Autoimmunity"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune Signaling in Neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ana.24398","article-title":"Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus","volume":"77","author":"Michailidou","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","article-title":"Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease","volume":"52","author":"Werneburg","year":"2020","journal-title":"Immunity"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbi.2020.03.004","article-title":"Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis","volume":"87","author":"Hammond","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.165.10.5867","article-title":"Attenuation of Experimental Autoimmune Demyelination in Complement-Deficient Mice","volume":"165","author":"Nataf","year":"2000","journal-title":"J. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2013.04.021","article-title":"IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis","volume":"261","author":"Xu","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.2008.03830.x","article-title":"Complement in multiple sclerosis: Its role in disease and potential as a biomarker","volume":"155","author":"Ingram","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eplepsyres.2017.07.016","article-title":"Chemokines as new inflammatory players in the pathogenesis of epilepsy","volume":"136","author":"Cerri","year":"2017","journal-title":"Epilepsy Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: Excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/glia.23006","article-title":"Microglia-Neuron Communication in Epilepsy","volume":"65","author":"Eyo","year":"2017","journal-title":"Glia"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03702.x","article-title":"Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease","volume":"53","author":"Kooij","year":"2012","journal-title":"Epilepsia"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular Intercommunication between the Complement and Coagulation Systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/neu.2019.6942","article-title":"Complement in the Development of Post-Traumatic Epilepsy: Prospects for Drug Repurposing","volume":"37","author":"Chen","year":"2020","journal-title":"J. Neurotrauma"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-160488","article-title":"Inflammation, Antiinflammatory Agents, and Alzheimer\u2019s Disease: The Last 22 Years","volume":"54","author":"McGeer","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","article-title":"Complement activation in experimental and human temporal lobe epilepsy","volume":"26","author":"Aronica","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1523\/JNEUROSCI.2766-06.2006","article-title":"Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy","volume":"26","author":"Gorter","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Jamali, S., Salzmann, A., Perroud, N., Ponsole-Lenfant, M., Cillario, J., Roll, P., Roeckel-Trevisiol, N., Crespel, A., Balzar, J., and Schlachter, K. (2010). Functional Variant in Complement C3 Gene Promoter and Genetic Susceptibility to Temporal Lobe Epilepsy and Febrile Seizures. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012740"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00429-013-0528-4","article-title":"MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy","volume":"219","author":"Kharatishvili","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2017.09.005","article-title":"Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment","volume":"137","author":"Liguori","year":"2017","journal-title":"Epilepsy Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.expneurol.2017.06.009","article-title":"Enhanced classical complement pathway activation and altered phagocytosis signaling molecules in human epilepsy","volume":"295","author":"Wyatt","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2017.10.012","article-title":"Status epilepticus triggers long-lasting activation of complement C1q-C3 signaling in the hippocampus that correlates with seizure frequency in experimental epilepsy","volume":"109","author":"Schartz","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3349\/ymj.2008.49.1.1","article-title":"Role of Brain Inflammation in Epileptogenesis","volume":"49","author":"Choi","year":"2008","journal-title":"Yonsei Med. J."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1523\/JNEUROSCI.23-03-00955.2003","article-title":"Formation of Complement Membrane Attack Complex in Mammalian Cerebral Cortex Evokes Seizures and Neurodegeneration","volume":"23","author":"Xiong","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"e00433","DOI":"10.1042\/BSR20160290","article-title":"Modulation of miR-146a\/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy","volume":"36","author":"He","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nbd.2015.02.004","article-title":"A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models","volume":"76","author":"Benson","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"112705","DOI":"10.1016\/j.physbeh.2019.112705","article-title":"Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus","volume":"212","author":"Schartz","year":"2019","journal-title":"Physiol. Behav."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Brewster, A.L., Lugo, J.N., Patil, V.V., Lee, W.L., Qian, Y., Vanegas, F., and Anderson, A.E. (2013). Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057808"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/brain\/awu350","article-title":"Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering","volume":"138","author":"Dachet","year":"2014","journal-title":"Brain"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"24988","DOI":"10.1038\/srep24988","article-title":"Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus","volume":"6","author":"Schartz","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature18283","article-title":"A complement-microglial axis drives synapse loss during virus-induced memory impairment","volume":"534","author":"Vasek","year":"2016","journal-title":"Nature"},{"key":"ref_216","first-page":"177","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_217","first-page":"19","article-title":"Complement C3 Expression Is Decreased in Autism Spectrum Disorder Subjects and Contributes to Behavioral Deficits in Rodents","volume":"3","author":"Fagan","year":"2017","journal-title":"Mol. Neuropsychiatry"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: An integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review","volume":"159","author":"Cannon","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","article-title":"Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk","volume":"77","author":"Cannon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","article-title":"Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?","volume":"17","author":"Feinberg","year":"1982","journal-title":"J. Psychiatr. Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","article-title":"The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia","volume":"81","author":"Howes","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Arakelyan, A., Zakharyan, R., Khoyetsyan, A., Poghosyan, D., Aroutiounian, R., Mrazek, F., Petrek, M., and Boyajyan, A. (2011). Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin. Pathol., 11.","DOI":"10.1186\/1472-6890-11-10"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2004.10.024","article-title":"Classical pathway complement activity in schizophrenia","volume":"374","author":"Hakobyan","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.psychres.2016.10.061","article-title":"Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia","volume":"246","author":"Li","year":"2016","journal-title":"Psychiatry Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","article-title":"In vivo immunomodulatory effects of clozapine in schizophrenia","volume":"26","author":"Maes","year":"1997","journal-title":"Schizophr. Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1358\/dnp.2008.21.4.1213349","article-title":"The complement system in schizophrenia","volume":"21","author":"Mayilyan","year":"2008","journal-title":"Drug News Perspect."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S0033291700028397","article-title":"Reduced total complement haemolytic activity in schizophrenic patients","volume":"23","author":"Spivak","year":"1993","journal-title":"Psychol. Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2014.07.053","article-title":"Maternal complement C1q and increased odds for psychosis in adult offspring","volume":"159","author":"Severance","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"(2014). Hon-Cheong Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nat. Cell Biol., 511, 421\u2013427.","DOI":"10.1038\/nature13595"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"The International Schizophrenia Consortium (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nat. Cell Biol., 460, 748\u2013752.","DOI":"10.1038\/nature08185"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, Ripke, S., Sanders, A.R., Kendler, K.S., Levinson, D.F., Sklar, P., Holmans, P.A., Lin, D.-Y., Duan, J., and Ophoff, R.A. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet., 43, 969\u2013976.","DOI":"10.1038\/ng.940"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/gbb.12016","article-title":"Neuropsychological effects of theCSMD1genome-wide associated schizophrenia risk variant rs10503253","volume":"12","author":"Donohoe","year":"2013","journal-title":"Genes Brain Behav."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1096\/fj.13-230706","article-title":"The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly","volume":"27","author":"Kalchishkova","year":"2013","journal-title":"FASEB J."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2014.02.017","article-title":"The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males","volume":"154","author":"Koiliari","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41398-018-0181-z","article-title":"Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study","volume":"8","author":"Prasad","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbrc.2018.02.131","article-title":"Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia","volume":"497","author":"Ishii","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2017.164","article-title":"Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans","volume":"43","author":"Allswede","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/mp.2017.151","article-title":"The complement system: A gateway to gene\u2013environment interactions in schizophrenia pathogenesis","volume":"22","author":"Nimgaonkar","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41380-019-0479-0","article-title":"The complement system in schizophrenia: Where are we now and what\u2019s next?","volume":"25","author":"Woo","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"E7049","DOI":"10.1073\/pnas.1604992113","article-title":"Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism","volume":"113","author":"Patel","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.autrev.2004.07.036","article-title":"Is autism an autoimmune disease?","volume":"3","author":"Ashwood","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2040-2392-5-46","article-title":"Dysregulation of estrogen receptor beta (ER\u03b2), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects","volume":"5","author":"Crider","year":"2014","journal-title":"Mol. Autism"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/s1679-45082017rb4020","article-title":"Autism spectrum disorders: An updated guide for genetic counseling","volume":"15","year":"2017","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/npp.2016.158","article-title":"The Role of the Immune System in Autism Spectrum Disorder","volume":"42","author":"Meltzer","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Rosenblat, J.D., and McIntyre, R.S. (2017). Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications. Brain Sci., 7.","DOI":"10.3390\/brainsci7110144"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Siniscalco, D., Schultz, S., Brigida, A.L., and Antonucci, N. (2018). Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders. Pharmaceuticals, 11.","DOI":"10.3390\/ph11020056"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2249.1991.tb05657.x","article-title":"Increased frequency of the null allele at the complement C4b locus in autism","volume":"83","author":"Warren","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.mp.4001943","article-title":"A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins","volume":"12","author":"Corbett","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"ref_255","first-page":"1","article-title":"High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders","volume":"2012","author":"Momeni","year":"2011","journal-title":"Autism Res. Treat."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2009.09.120","article-title":"Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders","volume":"1309","author":"Hutsler","year":"2010","journal-title":"Brain Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","article-title":"Identification of common genetic risk variants for autism spectrum disorder","volume":"51","author":"Grove","year":"2019","journal-title":"Nat. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4675\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:54:49Z","timestamp":1760162089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":258,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094675"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094675","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}